America's COVID death rate is much higher than in other wealthy nations, analysis finds. Here's why.
The U.S. has a slightly higher overall COVID-19 fatality rate than other high-income countries. But the death toll from the Omicron wave has really "set the country apart — and by wider margins than has been broadly recognized," The New York Times reported Tuesday night. "Since Dec. 1, when health officials announced the first Omicron case in the United States, the share of Americans who have been killed by the coronavirus is at least 63 percent higher than in any of these other large, wealthy nations."
Given Omicron's decreased severity, U.S. officials and experts had hoped the country could avoid another deadly wave, as some other countries had. It did not work out that way.
"Some of the reasons for America's difficulties are well known," the Times reports. "Despite having one of the world's most powerful arsenals of vaccines, the country has failed to vaccinate as many people as other large, wealthy nations," especially older Americans, and the U.S. "has fallen even further behind in administering booster shots." A recent Financial Times analysis found that the current U.S. hospitalization rate would be much lower if the U.S. had Britain's vaccination rate.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Americans are now dying at twice the rate of Britons and four times the rate of Germans, the Times found. In Britain, only 4 percent of people 65 and older are not fully vaccinated and 9 percent haven't been boosted. In the U.S., 12 percent of people 65 and older haven't been fully vaccinated and 43 percent haven't gotten a booster shot.
Vaccinations and boosters aren't the only explanations for why the U.S. is lagging behind its wealthy peers. Many Americans are obese or have diabetes, increasing the risks of severe COVID-19. And Americans trust the government and each other less. That trust deficit helps explain why the U.S. fared worse than poorer countries with less robust health care systems, The Washington Post reports, citing a peer-reviewed study of 117 countries published Tuesday in The Lancet.
"We found no links between COVID outcomes and democracy, populism, government effectiveness, universal health care, pandemic preparedness metrics, economic inequality, or trust in science," said co-author Thomas Bollyky at the Council on Foreign Relations. "What our study suggests is that when you have a novel contagious virus," he added, "the best way for the government to protect its citizens is to convince its citizens to protect themselves."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
China and India's dam war in the Himalayas
Under The Radar Delhi's response to Beijing's plans for a huge dam in Tibet? Build a huge dam of its own right nearby
By Chas Newkey-Burden, The Week UK Published
-
Born this way
Opinion 'Born here, citizen here' is the essence of Americanism
By Mark Gimein Published
-
What does Trump's immigration crackdown mean for churches?
Today's Big Question Mass deportations come to 'sacred spaces'
By Joel Mathis, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
How close are we to a norovirus vaccine?
Today's Big Question A new Moderna trial raises hopes of vanquishing a stomach bug that sickens millions a year
By David Faris Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published
-
McDonald's sued over E. coli linked to burger
Speed Read The outbreak has sickened at least 49 people in 10 states and left one dead
By Rafi Schwartz, The Week US Published